New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Acorda Therapeutics (ACOR)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
71.2M
75.7M
77.4M
81.5M
71.9M
Cost of Revenue
12.6M
13.7M
14.9M
16.4M
13.6M
Gross Profit
58.6M
61.9M
62.5M
65.1M
58.2M
Research & Development
11.0M
12.6M
12.0M
18.2M
12.5M
SG&A
38.7M
44.2M
40.1M
45.6M
48.2M
Amortization & Deprec
0
0
0
0
0
Other Expenses
637K
233K
238K
220K
0
Total Operating Expenses
50.4M
57.1M
52.4M
64.0M
60.7M
Operating Income
8.22M
4.83M
10.1M
1.10M
-2.50M
Other Income
0
0
0
-6000
-418K
EBIT
8.22M
4.83M
10.1M
1.10M
-2.91M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
0
0
0
Income Before Taxes
8.22M
4.83M
10.1M
1.10M
-2.91M
Income Taxes
372K
280K
533K
-132M
-1.77M
Net Income from Continuing Ops
7.85M
4.54M
9.59M
133M
-1.14M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
7.85M
4.54M
9.59M
133M
-1.14M
Preferred Dividends
0
0
0
0
0
Net Income to Common
7.85M
4.54M
9.59M
133M
-1.14M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour